27.02.2024 - PHILADELPHIA, Feb. 27, 2024 (GLOBE NEWSWIRE) - Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that management will .
Representatives of France s National Center for Scientific Research (CNRS) and the U.S. Department of Energy (DOE) have signed a new "Statement of Interest" in
Ten projects aimed at advancing next-generation science and technology have been awarded funding by Jefferson Lab for fiscal year 2024. These projects are suppo
Representatives of France s National Center for Scientific Research (CNRS) and the U.S. Department of Energy (DOE) have signed a new "Statement of Interest" in